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INTRODUCTION
Sysmex XN-1000 hematology analyzer is an automated 5-part diff analyzer (eosinophils, basophils, neutrophils, lymphocytes, and monocytes). Since 1980, automated blood cell counters have begun to replace manual examinations because they have better precision and accuracy, except to calculate platelet counts. The automatic blood cell counters from various factories also have generally provided eight complete hematological parameters with a leukocyte type count that can be three parts, five parts, or six parts in less than a minute requiring less than 200 µL of blood. The automation not only makes workload setting more efficient but also shortens inspection times so that it is expected to help the establishment [1] [2] [3] [4] of a diagnosis and therapy earlier.
The automated blood cell counters, moreover, has two basic principles namely impedance and 1-3 optical scatter. The impedance method made by Coulter in 1950 is the most commonly used method at present. Meanwhile, optical light scatter uses laser or non-laser light on automated blood cell counters.
The Sysmex XN-1000 hematology analyzer has an optical light scatter principle. The use of optical and hydrodynamic focusing detection aims to calculate and observe the size of cells using a laser beam. When the cell is through the sensing zone, the distribution of light is detected by the detector photos and converted into electrical signals. The number of signals produced is proportional to the number of cells that go through the sensing zone 2 during a specific period. The old 3-part diff analyzer is useful enough for screening leukocyte counts. However, a 5-part diff analyzer or a 6-part diff one has better sensitivity and specificity to detect cell distribution and morphological abnormalities, such as blasts and 1-5 nucleated erythrocytes.
The Sysmex XN-1000 hematology analyzer is known to no longer be considered as a 5-part diff analyzer but become a 6-part diff analyzer. It means that six leukocyte types can be calculated by the Sysmex XN-1000 hematology analyzer, namely eosinophils, basophils, neutrophils, lymphocytes, monocytes, and immature granulocyte. With the calculation of IG, which includes promyelocytes, myelocytes, and metamyelocytes, the Sysmex XN-1000 hematology analyzer can be said to be a Dengue virus has four serotype variants, namely DEN-1, DEN-2, DEN-3, and DEN-4. Dengue fever is an acute infectious disease caused by the dengue virus and characterized by symptoms of biphasic fever, myalgia, headache, pain in some parts of the body, rash, lymphadenopathy, and leukopenia. In most cases, DF is self-limited, but there is still a risk of progressively developing phase into DHF or DSS. Dengue virus infection can also trigger changes in the humoral immune system and cellular immune system.
The changes in the humoral immune system can be detected through the formation of IgG and IgM antibodies that can be identified through serological examination. Meanwhile, the changes in cellular immune system, according to some previous researchers, can be assessed by obtaining atypical lymphocytes that are typical for dengue infection, namely blue plasma lymphocytes considered as useful markers for early diagnosis with high sensitivity and specificity. It is because dengue virus infection can activate the immune system. Thus, impaired immune responses, such as inversion of the CD4/CD8 ratio not only can disrupt the ability of the immune system to clear the virus but also can cause excessive cytokine production which will affect T lymphocytes to differentiate into atypical 8 lymphocytes, especially blue plasma lymphocytes.
For those reasons, this research aimed to reveal whether HFLC would increase in DHF, since HFLC parameter in dengue fever could be used to estimate cellular immunity activities through the presence of blue plasma lymphocytes. This research used Sysmex XN-1000 hematology analyzer to evaluate HFLC values in patients.
METHODS
This research was a descriptive retrospective study conducted from April to May 2017. The subjects of this research were adult patients aged older 17 years old and diagnosed with dengue hemorrhagic fever according to WHO criteria. Serology test was also carried out to support the diagnosis of dengue hemorrhagic fever infection. Anamnesis, physical examination, and venous blood examination with HFLC then were performed on the subjects when they arrived at Mitra Keluarga Waru Hospital, Sidoarjo.
Moreover, clinical criteria for DHF used in this research were based on the WHO, such as an increase in hematocrit as much as >20% (hemoconcentration) or plasma leakage. Diagnosis of DHF then could be established if there were two clinical criteria plus one criterion for laboratory fulfilled (minimum increase in hematocrit), such as sudden fever for 2-7 days usually considered to be biphasic, bleeding tendency (petechiae, ecchymosis or purpura), thrombocytopenia 3 (<100,000/mm ), and/or leak plasma. Meanwhile, the diagnosis of DSS could be established if clinical DHF criteria were obtained plus circulation failure. Serologically, dengue infection could be detected if anti-dengue IgM and or IgG results were positive. Next, a regular blood test was performed to screen hemoglobin levels, hematocrit, platelet counts, and peripheral blood smear in DF suspect patients to detect the presence of relative lymphocytosis and blue plasma lymphocytes. Hence, HFLC examination was carried out using Sysmex XN-1000 on those patients diagnosed with dengue hemorrhagic fever based on the results of anamnesis, physical examination, and laboratory examination to detect their HFLC values. Before that, the normal range of HFLC values was determined by analyzing the blood cells of normal patients, and then its average value and standard deviation were measured.
RESULTS AND DISCUSSION
2017, a range of normal HFLC values was determined from 48 healthy people who did medical check-ups. A range of normal HFLC values obtained was between 0.0 -1.4% with an average value of 0.3% and a standard deviation of 2.71%.
In this research, 47 patients with dengue hemorrhagic fever became samples of the study. The frequency distribution of those patients by age then indicated that those patients were mostly 18 years old (19.6%). Meanwhile, the frequency distribution of patients by sex revealed that the patients were primarily female (52.2%) (Figure 1) .
Furthermore, HFLC values obtained from those 47 samples were from 2.0 to 32.3% with an average value of 11.6% and a standard deviation of 7.45%.
Based on Figure 2 , there was an increase in HFLC values of 47 samples compared to normal ones. The normal values of HFLC in the research were 0.0-1.4%, whereas in those patients with dengue hemorrhagic fever the values of HFLC were between 2.0-32.3% with an average value of 11.6% and a standard deviation of 7.45%. The increased HFLC values can be related to the pathogenesis of dengue hemorrhagic fever.
During the period of research from April to May types of the opposite immune responses, immune responses to prevent and cure dengue virus infections and immunopathological responses triggering clinical manifestations of DHF. Dengue virus stimulates monocyte cells to produce IFN-γ from lymphocytes through non-specific immune responses. IFN-γ induction requires contact between monocytes infected with the dengue virus and these lymphocytes. Non-infected monocytes will not stimulate autologous lymphocytes to produce IFN-γ. IFN-γ will protect monocytes that have not been 9 infected from the dengue virus.
Subsequently, the dengue virus will stimulate B-lymphocytes to produce interferon (IFN) through a specific mononuclear immune response to antigens DEN-1, DEN-2, DEN-3, and DEN-4. B-lymphocytes give a high response to the DEN-3 antigen, but a low one to the DEN-1, DEN-2, and DEN-4 antigens. This process proves the occurrence of cross responses between each different serotype. As a result, formation of dengue virus and antibody complexes, activation of T lymphocyte, activation of the c o m p l e m e n t s y s t e m , a n d p r o d u c t i o n o f pro-inflammatory and anti-inflammatory cytokines 9 occur.
Previous research argued that there were two complexes occur when viruses circulating in the blood circulation, most of which will bind to IgG specific antibodies to form immune complexes. Some researchers even get 48-72% of DHF patients with immune complexes. The immune complexes are found on platelet surfaces, B-lymphocytes, capillary walls, and kidney glomeruli. The immune complexes attached to platelets by the liver and spleen reticuloendothelial cells can lead to thrombocytopenia. Examination of provoked platelet Aggregation Adenosine Diphosphate (ADP) then proves that there is impaired platelet function. Hence, the activation of immune complexes in the endothelium will result in activation of coagulation resulting in coagulation defects, and coupled with thrombocytopenia causing bleeding in 9 DHF.
T-lymphocytes play an essential role in the pathogenesis of DHF. Activation of T-lymphocytes will cause the release of mediators that play an essential role in capillary permeability and blood clotting cascade. In 20-50% of cases, lymphocyte transformation occurs, which then will affect lymphocyte activation. In the acute phase, T-lymphocytes will decrease and then will return to the normal one in the healing period. Immune status before illness, however, can also affect the activation Therefore, an increase in HFLC in DHF patients can indicate that B-lymphocytes, T-lymphocytes, or monocytes are activated well according to the pathogenesis of DHF. But, during the healing period, activated lymphocytes will decrease and cause HFLC to decrease in number, along with an increase in the number of thrombocytes.
CONCLUSION AND SUGGESTIONS
Based on the results of this research, it can be concluded that in dengue hemorrhagic fever, an immunological response, both humoral immune response and cellular immune response, can occur. This immunological response is triggered by activation of B-lymphocytes, T-lymphocytes, or monocytes. The immunological response can be 
